HK1081959A1 - Thienopyriminediones and their use in the modulation of autoimmune disease - Google Patents
Thienopyriminediones and their use in the modulation of autoimmune diseaseInfo
- Publication number
- HK1081959A1 HK1081959A1 HK06102161A HK06102161A HK1081959A1 HK 1081959 A1 HK1081959 A1 HK 1081959A1 HK 06102161 A HK06102161 A HK 06102161A HK 06102161 A HK06102161 A HK 06102161A HK 1081959 A1 HK1081959 A1 HK 1081959A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- sup
- thienopyriminediones
- modulation
- autoimmune disease
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0300119A SE0300119D0 (sv) | 2003-01-17 | 2003-01-17 | Novel compounds |
PCT/SE2004/000052 WO2004065394A1 (en) | 2003-01-17 | 2004-01-15 | Thienopyrimidinediones and their use in the modulation of autoimmune disease |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1081959A1 true HK1081959A1 (en) | 2006-05-26 |
Family
ID=20290154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06102161A HK1081959A1 (en) | 2003-01-17 | 2006-02-17 | Thienopyriminediones and their use in the modulation of autoimmune disease |
Country Status (24)
Country | Link |
---|---|
US (2) | US7384951B2 (is) |
EP (1) | EP1587812B1 (is) |
JP (1) | JP4519121B2 (is) |
KR (2) | KR20110125256A (is) |
CN (1) | CN100334093C (is) |
AT (1) | ATE335748T1 (is) |
AU (1) | AU2004206012B2 (is) |
BR (1) | BRPI0406801B8 (is) |
CA (1) | CA2512441C (is) |
DE (1) | DE602004001857T2 (is) |
EG (1) | EG25613A (is) |
ES (1) | ES2270337T3 (is) |
HK (1) | HK1081959A1 (is) |
IL (1) | IL169370A (is) |
IS (1) | IS2376B (is) |
MX (1) | MXPA05007496A (is) |
NO (1) | NO333702B1 (is) |
NZ (1) | NZ541217A (is) |
PL (1) | PL214682B1 (is) |
RU (1) | RU2331647C2 (is) |
SE (1) | SE0300119D0 (is) |
UA (1) | UA81788C2 (is) |
WO (1) | WO2004065394A1 (is) |
ZA (1) | ZA200505364B (is) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0117583D0 (en) | 2001-07-19 | 2001-09-12 | Astrazeneca Ab | Novel compounds |
GB0118479D0 (en) * | 2001-07-28 | 2001-09-19 | Astrazeneca Ab | Novel compounds |
JP2006515880A (ja) * | 2003-01-17 | 2006-06-08 | アストラゼネカ・アクチエボラーグ | 自己免疫疾患の調節におけるチエノピリダジノンとその使用 |
SE0300120D0 (sv) | 2003-01-17 | 2003-01-17 | Astrazeneca Ab | Novel compounds |
CA2550361C (en) | 2003-12-19 | 2014-04-29 | Prabha Ibrahim | Compounds and methods for development of ret modulators |
US7498342B2 (en) | 2004-06-17 | 2009-03-03 | Plexxikon, Inc. | Compounds modulating c-kit activity |
JP2008545652A (ja) | 2005-05-17 | 2008-12-18 | プレキシコン,インコーポレーテッド | c−kitおよびc−fms活性を調節する化合物およびその用途 |
NZ565255A (en) | 2005-06-22 | 2010-04-30 | Plexxikon Inc | Pyrrolo[2,3-b] pyridine derivatives as protein kinase inhibitors |
WO2008063888A2 (en) | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
WO2008079909A1 (en) | 2006-12-21 | 2008-07-03 | Plexxikon, Inc. | Pyrrolo [2,3-b] pyridines as kinase modulators |
PE20081581A1 (es) | 2006-12-21 | 2008-11-12 | Plexxikon Inc | COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA |
US7872018B2 (en) | 2006-12-21 | 2011-01-18 | Plexxikon, Inc. | Compounds and methods for kinase modulation, and indications therefor |
GB0713479D0 (en) * | 2007-07-11 | 2007-08-22 | Syngenta Participations Ag | Substituted aromatic heterocyclic compounds as fungicides |
US20100190777A1 (en) | 2007-07-17 | 2010-07-29 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
WO2010089580A1 (en) | 2009-02-06 | 2010-08-12 | Astrazeneca Ab | Use of a mct1 inhibitor in the treatment of cancers expressing mct1 over mct4 |
BRPI1009372A2 (pt) * | 2009-03-23 | 2016-05-31 | Glenmark Pharmaceuticals Sa | compostos, composição farmacêutica e respectivos usos |
KR20110128898A (ko) * | 2009-03-23 | 2011-11-30 | 그렌마크 파머수티칼스 에스. 아. | Trpa1 조절자로서 푸로피리미딘디온 유도체 |
EP2414356B1 (en) | 2009-04-03 | 2015-09-02 | F.Hoffmann-La Roche Ag | Propane-i-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide compositions and uses thereof |
US8329724B2 (en) | 2009-08-03 | 2012-12-11 | Hoffmann-La Roche Inc. | Process for the manufacture of pharmaceutically active compounds |
MX2012005284A (es) | 2009-11-06 | 2012-06-28 | Plexxikon Inc | Compuestos y metodos para la modulacion de cinasas. e indicaciones para ello. |
AU2012214762B2 (en) | 2011-02-07 | 2015-08-13 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
TWI558702B (zh) | 2011-02-21 | 2016-11-21 | 普雷辛肯公司 | 醫藥活性物質的固態形式 |
EP2804852A2 (en) | 2012-01-20 | 2014-11-26 | Regents Of The University Of Minnesota | Therapeutic compounds |
GB2523211B (en) | 2012-01-27 | 2020-03-18 | Univ Jefferson | MCT protein inhibitor-related prognostic and therapeutic methods |
US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
US10022372B2 (en) | 2013-04-19 | 2018-07-17 | Thomas Jefferson University | Caveolin-1 related methods for treating glioblastoma with temozolomide |
NZ718576A (en) * | 2013-10-21 | 2019-11-29 | Genosco | Substituted pyrimidine compounds and their use as syk inhibitors |
WO2016118825A1 (en) * | 2015-01-22 | 2016-07-28 | The Scripps Research Institute | Heterocyclic inhibitors of monocarboxylate transporters |
UY36586A (es) * | 2015-03-26 | 2016-10-31 | Bayer Pharma AG | Heterociclilmetiltienouracilos y uso de los mismos |
KR101730536B1 (ko) * | 2016-03-17 | 2017-05-02 | 주식회사 골프존 | 스크린 골프 시스템에서 구현되는 컨텐츠 전송 서비스 방법, 컨텐츠 전송 서비스를 위한 모바일 단말기의 제어방법 및 이를 기록한 컴퓨팅 장치에 의해 판독 가능한 기록매체 |
KR101712838B1 (ko) * | 2016-03-17 | 2017-03-07 | 주식회사 골프존 | 가상 골프 시뮬레이션 장치, 가상 골프를 위한 영상 구현 방법 및 이를 기록한 컴퓨팅 장치에 의해 판독 가능한 기록 매체 |
KR101712836B1 (ko) * | 2016-03-17 | 2017-03-22 | 주식회사 골프존 | 가상 골프 시뮬레이션 장치, 가상 골프를 위한 영상 구현 방법 및 이를 기록한 컴퓨팅 장치에 의해 판독 가능한 기록 매체 |
TWI823932B (zh) | 2018-05-11 | 2023-12-01 | 中國大陸商迪哲(江蘇)醫藥有限公司 | 三唑并嘧啶化合物及其在治療癌症中之用途 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US738495A (en) * | 1902-12-26 | 1903-09-08 | William E Sherwood | Thill-coupling. |
SE9702001D0 (sv) * | 1997-05-28 | 1997-05-28 | Astra Pharma Prod | Novel compounds |
US6469014B1 (en) * | 1997-05-28 | 2002-10-22 | Astrazeneca Ab | Thieno[2,3-d] pyrimidinediones, their preparation and use in therapy |
CN1284079A (zh) | 1997-12-05 | 2001-02-14 | 阿斯特拉曾尼卡英国有限公司 | 新化合物 |
US6232320B1 (en) * | 1998-06-04 | 2001-05-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
EP1107973B1 (en) | 1998-08-28 | 2003-11-05 | AstraZeneca AB | NOVEL THIENO[2,3-d]PYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION AND USE THEREOF IN THERAPY |
EP1280806B1 (en) * | 2000-05-04 | 2004-08-04 | AstraZeneca AB | THIENO 2,3-d]PYRIMIDINEDIONES AND THEIR USE AS PHARMACEUTICALS |
GB0117583D0 (en) * | 2001-07-19 | 2001-09-12 | Astrazeneca Ab | Novel compounds |
GB0118479D0 (en) * | 2001-07-28 | 2001-09-19 | Astrazeneca Ab | Novel compounds |
SE0300120D0 (sv) * | 2003-01-17 | 2003-01-17 | Astrazeneca Ab | Novel compounds |
JP2006515880A (ja) * | 2003-01-17 | 2006-06-08 | アストラゼネカ・アクチエボラーグ | 自己免疫疾患の調節におけるチエノピリダジノンとその使用 |
-
2003
- 2003-01-17 SE SE0300119A patent/SE0300119D0/xx unknown
-
2004
- 2004-01-15 KR KR1020117022785A patent/KR20110125256A/ko not_active Application Discontinuation
- 2004-01-15 EP EP04702477A patent/EP1587812B1/en not_active Expired - Lifetime
- 2004-01-15 PL PL378222A patent/PL214682B1/pl unknown
- 2004-01-15 MX MXPA05007496A patent/MXPA05007496A/es active IP Right Grant
- 2004-01-15 KR KR1020057013126A patent/KR101107486B1/ko active IP Right Grant
- 2004-01-15 RU RU2005121494/04A patent/RU2331647C2/ru not_active IP Right Cessation
- 2004-01-15 DE DE602004001857T patent/DE602004001857T2/de not_active Expired - Lifetime
- 2004-01-15 NZ NZ541217A patent/NZ541217A/en not_active IP Right Cessation
- 2004-01-15 WO PCT/SE2004/000052 patent/WO2004065394A1/en active IP Right Grant
- 2004-01-15 UA UAA200506377A patent/UA81788C2/uk unknown
- 2004-01-15 AU AU2004206012A patent/AU2004206012B2/en not_active Ceased
- 2004-01-15 US US10/542,197 patent/US7384951B2/en not_active Expired - Lifetime
- 2004-01-15 CN CNB2004800071073A patent/CN100334093C/zh not_active Expired - Fee Related
- 2004-01-15 CA CA2512441A patent/CA2512441C/en not_active Expired - Lifetime
- 2004-01-15 AT AT04702477T patent/ATE335748T1/de not_active IP Right Cessation
- 2004-01-15 ES ES04702477T patent/ES2270337T3/es not_active Expired - Lifetime
- 2004-01-15 JP JP2006500750A patent/JP4519121B2/ja not_active Expired - Fee Related
- 2004-01-15 BR BRPI0406801A patent/BRPI0406801B8/pt not_active IP Right Cessation
-
2005
- 2005-06-23 IL IL169370A patent/IL169370A/en active IP Right Grant
- 2005-07-01 ZA ZA2005/05364A patent/ZA200505364B/en unknown
- 2005-07-12 EG EGNA2005000380 patent/EG25613A/xx active
- 2005-07-29 IS IS7965A patent/IS2376B/is unknown
- 2005-08-15 NO NO20053826A patent/NO333702B1/no not_active IP Right Cessation
-
2006
- 2006-02-17 HK HK06102161A patent/HK1081959A1/xx not_active IP Right Cessation
-
2008
- 2008-05-05 US US12/115,171 patent/US20080214579A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG25613A (en) | Thienopyrimidinediones and their use in the modulation of autoimmune disease | |
HK1048990A1 (en) | Novel compounds. | |
PL366198A1 (en) | Novel compounds | |
TW200508214A (en) | Novel compounds | |
HK1084941A1 (en) | Compounds and their use | |
CA2481723A1 (en) | 5ht2c receptor modulators | |
DE602004021472D1 (en) | Pyrimiidinverbindungen | |
MXPA04004498A (es) | Derivados de n-adamantilmetil e intermediarios como composiciones farmaceuticas y procesos para su preparacion. | |
DE60116761D1 (en) | Adamantanderivate | |
TW200613243A (en) | Novel compounds | |
AU2003228770A8 (en) | Substituted pyrazolopyrimidines | |
SE0300480D0 (sv) | Novel compounds | |
SE0302139D0 (sv) | Novel compounds | |
TW200604197A (en) | New compounds | |
SE0402925D0 (sv) | Novel Compounds | |
IL160171A0 (en) | Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
GB0104050D0 (en) | Chemical compounds | |
GB0120461D0 (en) | Novel compounds | |
IL172538A0 (en) | Depsipeptide compounds, pharmaceutical compositions containing the same and processes for the preparation thereof | |
SE0303280D0 (sv) | Novel compounds | |
MXPA02012426A (es) | Compuestos nuevos. | |
DE60201074D1 (en) | Pyrazolopyridinderivate | |
SE0202693D0 (sv) | Compounds | |
SE0302755D0 (sv) | Novel compounds | |
MXPA05007495A (es) | Tienopiridazinonas y su uso en la modulacion de enfermedades autoinmunes. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20210111 |